-
Dr. Hongwei Yao: Organ Preservation and Survival in Mid-Low Rectal Cancer with Radiotherapy and PD-1 Inhibitors
Oncology Frontier: Could you explain the unique value of combining long-course radiotherapy with PD-1 inhibitors in neoadjuvant therapy for mid-to-low rectal cancer? What advantages has this treatment strategy shown in…
-
Annual Review | Prof. Shuhua Yi: Highlights of 2024 Advances in Mantle Cell Lymphoma
In recent years, the field of hematologic oncology has experienced remarkable breakthroughs, with significant advancements in mantle cell lymphoma (MCL). Chinese researchers have increasingly contributed to this progress, playing a pivotal role in driving academic development and clinical practice in the field. As we step into the new year, Hematology Frontier invited Professor Shuhua Yi…
-
Dr. Rongbo Lin: Exploring the Clinical Pathology and Molecular Features of New Targets in Gastric Cancer
Advances in Molecular Subtyping of Gastric Cancer As research progresses, gastric cancer studies have transitioned from traditional histological classifications, such as Lauren and WHO classifications, to molecular subtyping, notably the…
-
Annual Review | Dr. Xiuying Xiao’s Team Highlights Advances in Colorectal Cancer Diagnosis and Treatment in 2024
Authors: Yongchao Wang, Ting Han, Xiaolin Lin, Xiuying Xiao I. New Strategies and Modalities in Perioperative Treatment The perioperative treatment of CRC witnessed the emergence of multiple innovative strategies in…
-
Annual Review | Dr. Liangyou Gu: Advances in Perioperative Treatment of Renal Cancer in 2024
Renal cancer is a common malignancy of the urinary system. For localized and locally advanced renal cancer without distant or extraregional lymph node metastases, surgical removal of the tumor or the affected kidney remains the primary treatment. Recent advances in targeted therapy and immunotherapy have expanded the options for perioperative treatment of renal cancer. In…
-
CTI 2024丨Dr. Didier Blaise Discusses the Impact of Conditioning Regimens on Transplant Success in Elderly Patients
Q1: Conditioning regimens can affect the incidence of post-transplant complications. How can we balance the intensity of conditioning regimens with reducing the risk of complications for elderly patients? Dr. Didier…
-
CTI 2024丨Dr. Herbert Kim Lyerly: Advances and Future Prospects in Cell and Gene Therapy
Key Highlights Dr. Herbert Kim Lyerly: The current focus of cell and gene therapy lies in its exceptional effectiveness in treating certain cancers, and it is now being extended to…
-
CTI 2024丨Dr. Jean-Luc Harousseau on the Advances and Challenges of Immunotherapy in Multiple Myeloma
Q1: How does immunotherapy compare to traditional therapies in terms of strengths and limitations? How can these treatments be balanced in clinical practice? Dr. Jean-Luc Harousseau: Immunotherapy stands apart from…
Connecting Medical Expertise through Media